Clinical Efficacy of Chlorhexidine Varnish in Reducing Gingival Hyperplasia, Plaque Accumulation, and White Spot Lesions in Orthodontic Patients

NARecruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 21, 2025

Primary Completion Date

September 29, 2025

Study Completion Date

October 15, 2025

Conditions
Gingival HyperplasiaDental PlaqueTooth Demineralization
Interventions
DRUG

Chlorhexidine Varnish

A 40% chlorhexidine varnish formulation (40% chlorhexidine, 36% sandarac, 24% ethanol) applied topically to the buccal surfaces of teeth in the selected upper quadrant. The varnish is applied using a blunt needle syringe before bonding and at monthly follow-up visits for three months. Teeth are dried before application, and patients are instructed not to eat or drink for 3 hours and to avoid brushing until the next day.

DRUG

Placebo Varnish

A placebo varnish composed of 60% sandarac and 40% ethanol applied topically in the same manner and frequency as the chlorhexidine varnish. Used on the opposite quadrant of the same patient in a split-mouth design. Participants are blinded to whether chlorhexidine or placebo was applied.

Trial Locations (1)

09152

RECRUITING

Sardar Begum Dental College & Hospital, Peshawar

All Listed Sponsors
collaborator

Gandhara University

OTHER

lead

Khyber Medical University Peshawar

OTHER

NCT07115784 - Clinical Efficacy of Chlorhexidine Varnish in Reducing Gingival Hyperplasia, Plaque Accumulation, and White Spot Lesions in Orthodontic Patients | Biotech Hunter | Biotech Hunter